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Abstract
Background: Long-acting reversible contraception (LARC) can assist women with birth spacing and reduce
unintended pregnancies. Sub-Saharan Africa has low uptake of the two available methods of LARC, the subdermal
implant and intrauterine contraception (IUC). Our primary objectives were to: 1) calculate the incidence of LARC use
among postpartum Malawian women, and 2) assess if LARC knowledge and intent to use LARC were associated with
LARC uptake.
Methods: This study was a prospective cohort study of 634 postpartum women who were recruited from the
postpartum ward of Bwaila Hospital in Lilongwe, Malawi. Study participants completed a baseline survey in
the postpartum ward. Follow-up telephone surveys about contraceptive use were conducted at 3, 6, and 12 months
postpartum. Cox proportional hazards regression analysis was performed to evaluate if implant knowledge and intent
to use implant were associated with implant uptake.
Results: One hundred thirty-seven implant and 10 IUC placements were reported over 12 months of follow-up; given
the low rate of IUC uptake, further analysis was only done for implant uptake. The incidence rate for implant uptake
was 35.6 per 100 person-years (95 % CI 30.0, 42.2). Correct implant knowledge (adjusted HR = 1.69; 95 % CI 1.06, 2.68)
and intent to use implant (adjusted HR 1.95; 95 % CI 1.28, 2.98) were both associated with implant uptake.
Conclusions: More women reported implant use than IUC use in our study. Correct implant knowledge and intent to
use implant were both associated with implant uptake, with a stronger association for intent. Interventions to increase
LARC uptake should focus on improving LARC knowledge and removing barriers to LARC.
Trial registration: Clinical Trial Registration #: NCT01893021
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Background
Sub-Saharan Africa has high rates of unintended preg-
nancy, which contributes to adverse maternal, perinatal,
and infant outcomes [1–3]. Subdermal implants and
intrauterine contraception (IUC) are the most effective
reversible contraceptives and are known as “long-acting
reversible contraception” (LARC) [4, 5]. However, they
are used by less than 3 % of reproductive-aged women
(which includes postpartum women) in sub-Saharan
Africa, including in Malawi [6, 7]. In Malawi, where
45 % of pregnancies are unintended, a recent study
found that 97 % of postpartum women did not desire
another pregnancy in the 2 years after delivery [7, 8]. In-
creasing LARC uptake among postpartum women may
help to reduce both unintended pregnancies and
lengthen interpregnancy intervals [9–11].
Understanding the modifiable characteristics of
women who initiate and continue LARC in the first year
postpartum can help guide strategies to increase LARC
uptake. Low rates of LARC uptake may stem from lack
of interest, accurate knowledge, [12, 13] peer and part-
ner support, or access [14, 15]. For our study, we chose
to focus on the potential associations between LARC
knowledge and intent to use LARC with LARC uptake.
Correct LARC knowledge may increase intent to use
LARC, which can then lead to increased LARC uptake if
other barriers to LARC do not exist. Therefore, our pri-
mary objectives were to: 1) calculate the incidence rate
of LARC use among postpartum Malawian women, and
2) assess if LARC knowledge and intent to use LARC
were associated with LARC uptake. Our secondary ob-
jectives were to describe barriers to LARC uptake and
reasons for discontinuation among LARC users.
Methods
Study setting and population
We conducted a prospective cohort study of postpartum
Malawian women who delivered between May-September
2013 [8]. Approval was obtained from the University of
North Carolina School of Medicine Institutional Review
Board and the Malawi National Health Sciences Research
Committee.
Women were recruited from the postnatal unit of
Bwaila Hospital, a district hospital in Lilongwe, Malawi,
with over 15,000 deliveries per year. Antenatal counsel-
ing on family planning is not provided in a standardized
fashion in the antenatal clinics due to the frequent rota-
tion of providers in the clinic and its high volume of
clients, but may be discussed if a client or provider
chooses to initiate a conversation about family planning.
Immediate postpartum contraception is not offered at
Bwaila. Two methods of LARC are available in Malawi:
the subdermal implant (both the etonogestrel and levo-
norgestrel implants) and the copper intrauterine device.
Study design
Women were recruited and enrolled from the postnatal
ward. The six inclusion criteria were: current admission
to the postpartum ward at Bwaila Hospital, age 18–45
years, live birth at greater than 28 weeks gestation,
fluency in English or Chichewa (the local language),
access to a working phone, and willingness to be con-
tacted by phone for up to 1 year postpartum. Eligible
women provided informed consent and completed a
30-min baseline survey focused on demographics,
family planning preferences, and knowledge of LARC.
Follow-up surveys were conducted by phone at approxi-
mately 3, 6, and 12 months after delivery and focused on
contraceptive uptake and continuation. Participants also
received a reminder phone call about the upcoming
12-month survey 9 months after delivery, but no survey
was administered. Women who missed a survey were not
contacted for subsequent surveys, although one participant
who had not completed either the 3- or 6-month survey
was inadvertently called for the 12-month survey and com-
pleted it. For women who were eligible to complete the
12-month survey, we attempted to contact these women
(up to 17 months postpartum) to complete this final survey
until all study participant contact ended in October 2014.
Variables
Timing of LARC uptake and continuation was based
on participants’ reported date of initiation or discon-
tinuation of these methods. Participants were consid-
ered to have correct knowledge about implant or IUC
efficacy if they answered that the LARC method was
more effective at preventing pregnancy than inject-
ables, which is known by 95 % of women in Malawi
[7]. Participants were also asked, “Do you think the
implant/IUC is a safe or unsafe form of family planning?”
Those who responded “safe” were determined to have
correct knowledge about LARC safety. Women were cate-
gorized as having correct implant knowledge if they an-
swered both the implant efficacy and safety question
correctly; they were categorized as having correct IUC
knowledge if they answered both the IUC efficacy and
safety questions correctly. Intention to use IUC or implant
was determined from the participant’s response at the
baseline survey when asked about the contraceptive
methods she was planning to use in the first year after de-
livery. At each follow-up call, women who were not using
an implant or IUC were asked if they would like to be cur-
rently using either of these methods, and if so, their reasons
for non-uptake. Similarly, women who had discontinued
LARC were asked about their reasons for discontinuation.
Sample Size
We determined that a convenience sample of approxi-
mately 630 postpartum women (210 HIV-infected women,
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420 HIV-uninfected women) would be necessary for
our primary study objective, which was to compare
baseline LARC knowledge between HIV-infected and
uninfected women (at a 1:2 ratio). The results of the
primary study objective have already been published
[8]. Since most of the women at the recruitment site
were HIV-uninfected, to maintain the 1:2 ratio we
capped the number of uninfected women that could
be enrolled each week, based on the number of HIV-
infected women that were enrolled that week.
Statistical analysis
All data were double entered into a REDCap data-
base, cleaned, merged, exported, and analyzed using
Stata Version 13.0 (StataCorp, College Station, TX).
Pearson’s χ2 tests were used to compare distributions
of categorical variables. For incidence rate calculations
and time to event analyses, the baseline survey was
the origin for survival time and participants were
followed until either time of implant uptake or last
completed survey date. We calculated incidence rates
and 95 % confidence intervals (CIs) of implant uptake
for each baseline variable for 100-person-years of ex-
posure time using the Stptime procedure in Stata.
The relationship between correct implant knowledge
and intent to use implant with time of implant up-
take was evaluated using unadjusted and adjusted
Cox proportional hazards regression models. We used
directed acyclic graphs to identify potential con-
founders for implant knowledge and intent to use
implant to include in the final adjusted models. We
estimated time to implant uptake by constructing
Kaplan-Meier survival curves and used the non-
parametric log-rank test to compare implant uptake
by our two predetermined variables, correct implant
knowledge and intent to use implant.
Results
Study population
We screened 799 women and 634 enrolled (Fig. 1). The
most common reason for non-enrollment was not hav-
ing access to a working phone (15 %). Follow-up data
were collected from 539 (85.0 %), 480 (75.7 %), and 331
(52.2 %) women at 3, 6, and 12 months, respectively.
The median age was 25 years (IQR 21, 29) and the mean
parity was 2 (IQR 1, 3).
Of the 634 women who enrolled, 613 (96.7 %)
responded to both survey questions about correct im-
plant knowledge and were included in the implant
knowledge analyses (Table 1). More women had correct
knowledge about the contraceptive implant than had
correct knowledge about IUC. Eighty-four percent cor-
rectly identified the implant as safe and 79.8 % correctly
said it was more effective than injectables, with 72.9 %
answering both implant knowledge questions correctly.
In contrast, 55.8 % of women correctly identified IUC as
safe, 46.5 % correctly identified IUC as more effective,
and 38.0 % answered both IUC knowledge questions
correctly. In addition, more women desired to use im-
plant (67.4 %) than desired to use IUC (19.7 %) at the
799 Screened for eligibility
634 women enrolled
539 completed 3-month survey 
(85%)
480 completed 6-month survey 
(72%)
331* completed 12-month 
survey (52%)
165 excluded for 
not meeting 
inclusion criteria
95 lost to 
follow-up









47 new LARC users
64 continuing LARC
1 discontinued LARC
368 never on LARC
102 using LARC
30 new LARC users  
72 continuing LARC 
5 discontinued LARC
224 never on LARC
69 using LARC
470 not using LARC
Fig. 1 Implant or intrauterine contraceptive (IUC) use among postpartum Malawian women up to 12 months after delivery. *One woman completed
the 12-month survey, but not the 3- or 6-month survey
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Table 1 Characteristics of women with and without correct implant knowledge at baseline
Correct Implant Knowledge (n = 462) Incorrect Implant Knowledge (n = 151) p-value
Age, n (%)
18–24 215 (46.5) 70 (46.4) 0.75
25–34 208 (45.0) 71 (47.0)
≥35 39 (8.4) 10 (6.6)
Relationship status, n (%)
Married 440 (95.2) 138 (91.4) 0.08
Unmarried 22 (4.8) 13 (8.6)
Education, n (%)
None or some primary 127 (27.5) 46 (30.5) 0.29
Primary/some secondary 217 (47.0) 60 (39.7)
Secondary and beyond 118 (25.5) 45 (29.8)
Trouble with food, clothing, or medications, n (%)a
Yes 254 (54.9) 91 (60.3) 0.28
No 206 (44.6) 60 (39.7)
Living children, n (%)
1 171 (37.0) 60 (39.7) 0.75
2–3 206 (44.6) 62 (41.1)
≥4 85 (18.4) 29 (19.2)
Desire any more children, n (%)a
Yes 286 (61.9) 88 (58.3) 0.72
No 167 (36.1) 59 (39.1)
Don’t know 7 (1.5) 3 (2.0)
Most recent pregnancy intention, n (%)
Intended 270 (58.4) 89 (58.9) 0.21
Unintended 192 (41.6) 61 (40.4)
Don’t know 0 (0.0) 1 (0.7)
HIV status, n (%)
Infected 157 (34.0) 49 (32.5) 0.73
Uninfected 305 (66.0) 102 (67.6)
Knowledge about IUC Safety and Efficacy, n (%)a
Correct 216 (46.8) 23 (15.2) <0.01
Incorrect/Don’t Know 216 (46.8) 116 (76.8)
Intent to use Implant, n (%)
Yes 343 (74.2) 71 (47.0) <0.01
No 119 (25.8) 80 (53.0)
Intent to use IUC, n (%)
Yes 88 (19.1) 32 (21.2) 0.56
No 374 (81.0) 119 (78.8)
Have friend using the implant, n (%)a
Yes 371 (80.3) 105 (69.5) 0.01
No 86 (18.6) 42 (27.8)
IUC intrauterine contraception
amay not add up to 100 % due to missing data
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time of the baseline survey. More women also reported a
friend using the implant (76.7 %) than a friend using IUC
(36.4 %). Women who responded with correct implant
knowledge were more likely to have correct IUC know-
ledge (p < 0.01), desire an implant (p < 0.01), and have a
friend who had used the implant (p = 0.01) (Table 1).
A total of 146 participants reported LARC use during
the follow-up period. LARC uptake was reported by 69
participants at the 3-month survey, another 47 partici-
pants at the 6-month survey, and an additional 30 par-
ticipants at the 12-month survey (Fig. 1). One-hundred
and thirty-seven implant and 10 IUC placements were
reported; one participant who had an implant placed
had it removed and had IUC placed instead. Of the im-
plant users, 101 (73.7 %) reported that they received
their implants from a government facility, whereas only
4 (40.0 %) IUC users received their method at a govern-
ment facility. Due to the small numbers of IUC users,
additional analyses were only performed on implant up-
take. Four implant users did not give a placement date
and were not included in time-to-event analysis.
Implant uptake varied by baseline intention to use the
implant. Of the 137 women who received an implant, 30
(21.9 %) did not plan to use it during the baseline survey;
43 (31.4 %) reported a plan to use both the implant and
another method; and 64 (46.7 %) reported a plan to use
only the implant. In contrast, only 2 (20.0 %) of the 10
women who initiated the IUC reported a plan to use only
IUC at baseline; 7 (70.0 %) did not report a plan to use it
at all at baseline, and the remaining woman (10.0 %) re-
ported a plan to use both IUC and another method.
Among the 331 women who reported that they wanted
to use the implant at a follow-up survey but did not initi-
ate it during the study, the most common reasons given
for not initiating were “currently using another method”
(52.0 %), “afraid of the side effects” (23.2 %), and “clinic
did not have it or said to come back for another appoint-
ment” (18.4 %). The reasons given for not initiating IUC
among the 59 women who reported that they wanted to
use IUC but did not initiate it were similar: 42.4 % were
“currently using another method”, 16.9 % were “afraid of
side effects”, and 10.2 % reported that the “clinic did not
have it or said to come back for another appointment”. In
total, 357 women reported that they wanted to use the im-
plant and/or IUC at a follow-up survey but were not using
it. When asked what family planning method they were
using instead, the majority (67.9 %) were using the contra-
ceptive injection, 7.5 % were using oral contraceptives,
4.4 % were using breastfeeding, and 20.1 % were using no
contraceptive method.
Main analyses
The median time for implant placement was 3 months
from delivery (IQR 2–5), which was the same as the
time to IUC placement (3 months; IQR 2–5). One hun-
dred and thirty-three implant uptakes were seen in 373.5
person-years of follow-up, at an incidence rate of 35.6
per 100 person-years (95 % confidence interval 30.0,
42.2) (Table 2). Women with correct baseline implant
knowledge had an implant incidence rate of 39.1 per 100
person-years [95 % CI 32.3, 47.4], whereas women with
incorrect implant knowledge had an implant incidence
rate of 24.0 per 100 person-years (95 % CI 16.0, 36.2),
which was not statistically significant. However, women
who had an intent to use the implant at baseline had a
statistically significant higher implant incident rate (42.7
per 100 person-years; 95 % CI 35.2, 51.8) than those
who did not intend to use it (22.7 per 100 person-years;
95 % CI 15.9, 32.4). Those women who had both correct
implant knowledge and an intent to use the implant at
baseline had a significantly higher implant incident rate
(44.8 per 100 person-years; 95 % CI 36.2, 55.3) than
those women who did not have both (25.9 per 100
person-years; 95 % CI 19.5, 34.5).
In the Kaplan-Meier survival analysis, women with
correct implant knowledge had a shorter time to im-
plant uptake than those with incorrect knowledge, as
did those who intended to use an implant at baseline
(Fig. 2). In unadjusted Cox proportional hazards re-
gression modeling, correct implant knowledge was as-
sociated with higher implant uptake (unadjusted HR
1.63; 95 % CI 1.04, 2.55). This association remained
significant (adjusted HR = 1.69; 95 % CI 1.06, 2.68)
when adjusted for age, parity, education, having a
friend using implant, and HIV status. Our Cox pro-
portional hazards regression model for intent to use
implant adjusted for age, parity, education, having a
friend using the implant, HIV status, and having
trouble obtaining food/clothing/medications. Both the
unadjusted HR (1.88; 95 % CI 1.25, 2.82) and adjusted
HR (1.95; 95 % CI 1.28, 2.98) for intent to use im-
plant at baseline were statistically significant.
Continuation analysis
Six women discontinued the implant; no women dis-
continued the IUC. Three women discontinued due
to heavy bleeding. Other reasons given for discon-
tinuation were abdominal pain or cramping (n = 2),
arm pain (n = 1), headache (n = 1), lightheadedness (n = 1),
weight loss (n = 1), and hypertension (n = 1). Half of these
women discontinued the implant 3–6 months after place-
ment (n = 3), and the rest discontinued between 6–12
months after placement. Due to the small number of
women who reported discontinuation of implant in the
study period, statistical analysis to examine the differences
between women who continued or discontinued implant
or IUC were not performed.
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Table 2 Incidence of Implant uptake by correct implant knowledge and covariates
Implant Uptake Events (n) Person-years Incidence Rate (per 100 person-years) 95 % CI of IR
Overall 133 373.5 35.6 (30.0, 42.2)
Implant Knowledge
Correct 105 268.3 39.1 (32.3, 47.4)
Incorrect 23 95.7 24.0 (16.0, 36.2)
Age categories
18–24 63 165.5 38.1 (29.7, 48.7)
25–34 60 174.6 34.4 (26.7, 44.3)
≥35 10 33.4 30.0 (16.1, 55.7)
Relationship status
Married 129 348.6 37.0 (31.1, 44.0)
Unmarried 4 24.9 16.1 (6.0, 42.8)
Education
None or some primary 29 95.7 30.3 (21.1, 43.6)
Primary/some secondary 62 162.0 38.3 (29.8, 49.1)
Secondary and beyond 42 115.9 36.2 (26.8, 49.1)
Trouble with food, clothing, or medications
Yes 69 194.8 35.4 (28.0, 44.8)
No 63 177.8 35.4 (27.7, 45.4)
Living children
1 47 144.2 32.6 (24.5, 43.4)
2–3 67 160.6 41.7 (32.8, 53.0)
≥4 19 68.7 27.7 (17.6, 43.4)
Desire any more children
Yes 82 233.9 35.1 (28.2, 43.5)
No 47 130.3 36.1 (27.1, 48.0)
Don’t know 3 8.0 37.4 (12.0, 115.8)
Most recent pregnancy intention
Intended 85 224.8 37.8 (30.6, 46.8)
Unintended 48 148.4 32.3 (24.4, 42.9)
Don’t know 0 - - -
HIV status
Infected 38 121.4 31.3 (22.8, 43.0)
Uninfected 95 252.1 37.7 (30.8, 46.1)
Intent to use Implant
Yes 103 241.2 42.7 (35.2, 51.8)
No 30 132.3 22.7 (15.9, 32.4)
Have friend using the implant
Yes 105 287.8 36.5 (30.1, 44.2)
No 26 79.1 32.8 (22.4, 48.3)
Both correct knowledge about implant and
intent to use implant
Yes 86 192.1 44.8 (36.2, 55.3)
No 47 181.4 25.9 (19.5, 34.5)
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Discussion
In this prospective cohort study of postpartum Malawian
women, we found a substantial proportion of women
initiating LARC with an implant uptake incidence rate
of 35.6 per 100 person-years. We also found that contra-
ceptive implants were utilized more than IUC. Women
with correct baseline implant knowledge and who
intended to use implant were more likely to initiate im-
plant. The association between intent to use implant and
implant uptake was stronger than the association be-
tween correct implant knowledge and implant uptake.
Interest, correct knowledge, and uptake were lower for
IUC than for implant in our study population, which is
consistent with other data from Malawi and sub-Saharan
Africa. In the 2010 Malawi Demographic Health Survey,
slightly more women between ages 15–49 years knew of
the implant (77.6 %) than IUC (73.8 %) [7]. In that same
survey, only had 1.7 % and 0.8 % of women had ever used
the implant and IUC, respectively. More women were cur-
rently using implant (1.1 %) than IUC (0.2 %). Studies from
Uganda and Ethiopia have also demonstrated lower know-
ledge about IUC than about implant or injectables [15, 16].
A Rwandan study of HIV-infected women followed for
9 months after delivery had a 10 times greater absolute im-
plant uptake than IUC uptake [17].
Low IUC uptake in Malawi is likely secondary to both
patient and provider misperceptions and barriers. A
cross-sectional study of 281 HIV-infected women
accessing care at an antiretroviral therapy clinic in
Lilongwe found that 25.4 % feared IUC placement and
25.4 % had heard negative things about IUC [18]. How-
ever, the same clinic found that after they integrated
family planning education and on-site IUC insertion,
165 (19 %) of the 859 women who initiated modern
contraception during their integration time period had
IUC inserted [19]. A recent mixed-methods study of 37
government family planning providers in Lilongwe Dis-
trict found that while providers had a generally favor-
able perception of IUC, only 11 (29.7 %) had received
any training in IUC, 6 (16.2 %) had inserted IUC during
their training, and 8 had ever-inserted IUC (21.6 %)
[20]. Some women in our study who were interested in
IUC stated that they were not using it because of clinic-
related issues or because they were already using an-
other method. The lack of experienced IUC providers
and high workload have likely resulted in limited avail-
ability of IUC at government health centers, where they
may opt to provide a less work-intensive method such
as the injectable or pills.
Although implant uptake was higher than IUC uptake
in our study, barriers to uptake for both LARC methods
were reported by our participants, and the majority of
women interested in LARC at baseline still had not re-
ceived it by the time they completed the 12-month
follow-up survey. Increasing knowledge of LARC and in-
tent to use LARC alone will not increase LARC uptake
if other barriers to LARC are not removed, which is
probably why the associations between these two charac-
teristics with LARC uptake were not very strong. The
clinic barriers and women’s fears about LARC must also
be addressed.
Other studies in sub-Saharan Africa have also shown
an association between contraceptive knowledge and
LARC use, although they used different measures for
contraceptive knowledge [15]. In a cross-sectional study
from South Africa, [21] contraceptive knowledge was
assessed through questions about IUC safety among
HIV-infected and breastfeeding women, side effects of
IUC, duration of effectiveness, and return to fertility
after removal. More than half of the participants in that
study did not have correct IUC knowledge for most of
these questions and no participants were currently using
IUC. Characteristics such as age, marital status, educa-
tion levels, and previous LARC use have been associated
a
b
Fig. 2 a Kaplan-Meier estimate of contraceptive implant uptake over
time by correct versus incorrect implant knowledge. * p = 0.030 by
log-rank test. b Kaplan-Meier estimate of contraceptive implant uptake
over time by intent to use implant at baseline. *p= 0.002 by log-rank test
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with LARC uptake in other sub-Saharan populations
[22, 23]. We did not find these characteristics to be asso-
ciated with LARC uptake in our population. Importantly,
these studies did not include postpartum women.
Our study differs also from other studies in that we
had a relatively high rate of postpartum implant up-
take when compared to other studies [13, 21, 24].
Our high rate of implant uptake may be due to the
design of this study. By asking women to complete a
survey regarding implant and IUC knowledge and in-
tentions, we may have increased LARC interest and
uptake. In addition, by limiting our study population
to women in an urban setting with access to a work-
ing telephone, we may have excluded women who
have more geographic and socioeconomic barriers to
receiving LARC and decreased the generalizability of
our findings. A Hawthorne (observer) bias also may
have increased LARC uptake in our study population
as women anticipating a call asking about LARC use
every 3 months may be more motivated to have
LARC placed. Women may have been tempted to re-
port LARC placement when this had not occurred, al-
though we attempted to minimize this social desirability
and information bias by asking for the exact date of LARC
placement. However, no verification of LARC use with
clinic records could be performed due to the study
methodology.
In addition, since we did not retain all women in this
study, we may be misestimating the proportion of
women using and discontinuing LARC. To explore the
potential effect of loss-to-follow-up, we compared the
baseline characteristics between the 540 women who
completed at least one follow-up survey with the 94
women who did not complete any follow-up surveys.
Women who did not complete any follow-up surveys
were less educated (p = 0.003) and less likely to have 2–3
living children (p = 0.015) than women who completed
at least one follow-up survey, but were otherwise similar.
Another limitation is that we used only two survey ques-
tions to categorize women as having correct implant
knowledge; other studies that use a different definition
of correct knowledge may result in different findings.
This prospective study is important because it is one
of the few published studies to describe patterns of
contraceptive uptake and discontinuation among post-
partum women with 1 year of follow-up in sub-Saharan
Africa. Other studies among postpartum women have
only been able to assess contraceptive uptake at hospital
discharge or within the first 3 months postpartum
[24, 25]. We were able to describe baseline character-
istics of women who used LARC over 1 year and the
timing of use and discontinuation. In addition, the
large sample size allowed us to do more in-depth
analyses of factors associated with implant use.
Future studies should focus on further understanding
the barriers to LARC uptake and implementing educa-
tional interventions to increase LARC knowledge. The
optimal nature of and timing of educational interven-
tions has not been established. Two studies have shown
that immediate postpartum education can increase
contraceptive use; one specifically showed an increased
in IUC use [26, 27]. Another study from the U.S.
showed increased LARC interest but not uptake with
an immediate postpartum script [24]. One study in
Zimbabwe found that contraceptive counseling during
antenatal care increased IUC knowledge, but not up-
take [28]. Educational campaigns through radio, [29]
billboards, and social media [30] have shown to be ef-
fective at increasing contraceptive uptake and continu-
ation in some studies.
Contraceptive knowledge can also be obtained outside
of the healthcare setting. Our study demonstrated that
having a friend with an implant was associated with cor-
rect implant knowledge, but not implant uptake. Studies
of adolescents in Nigeria [31] and undergraduates in
Tanzania [32] both found that the most common source
of contraceptive information was from their friends.
Therefore, social networks may play an important role
in contraceptive knowledge and uptake and could be tar-
geted as another intervention point.
Conclusions
In summary, to increase LARC uptake in postpartum
women, we need to focus on interventions to increase
correct contraceptive knowledge, which may be one step
towards increasing demand for and ultimately uptake of
LARC. We also need to ensure that women who intend
to use LARC are able to access it. Strategies to deter-
mine which types of educational interventions could be
successful at increasing LARC knowledge, uptake, and
continuation for postpartum women and enable them to
reach their fertility goals.
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